About Orbit Biomedical

About company

Orbit Biomedical’s mission is to revolutionize gene and cell therapy treatment by setting a new standard for precise, targeted surgical delivery. Our focus is to transform the accuracy, safety and consistency of delivering therapeutics to patients. Located in Philadelphia, Orbit Biomedical was founded in 2018 with a Series A investment from Syncona, a leading FTSE250 healthcare company focused on investing in and building global leaders in life science.